Overview

  • Product nameAnti-NOTCH3 antibody
    See all NOTCH3 primary antibodies
  • Description
    Rabbit polyclonal to NOTCH3
  • Tested applicationsSuitable for: IHC-Frmore details
  • Species reactivity
    Reacts with: Rat, Human
  • Immunogen

    Synthetic peptide representing the C terminal region of Human NOTCH3.

  • Positive control
    • Rat cerebellum

Properties

Applications

Our Abpromise guarantee covers the use of ab92758 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-Fr
  • Application notesIHC-Fr: 1/100 - 1/300.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionFunctions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs.
    • Tissue specificityUbiquitously expressed in fetal and adult tissues.
    • Involvement in diseaseDefects in NOTCH3 are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310]. CADASIL causes a type of stroke and dementia of which key features include recurrent subcortical ischemic events and vascular dementia. The disorder affects relatively young adults of both sexes. Mutations affect highly conserved cysteine residues within epidermal growth factor (EGF)-like repeat domains in the extracellular part of the receptor.
    • Sequence similaritiesBelongs to the NOTCH family.
      Contains 5 ANK repeats.
      Contains 34 EGF-like domains.
      Contains 3 LNR (Lin/Notch) repeats.
    • Post-translational
      modifications
      Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane.
      Phosphorylated.
    • Cellular localizationCell membrane and Nucleus. Following proteolytical processing NICD is translocated to the nucleus.
    • Information by UniProt
    • Database links
    • Alternative names
      • CADASIL antibody
      • CASIL antibody
      • NOTC3_HUMAN antibody
      • Notch 3 antibody
      • Notch 3 intracellular domain antibody
      • Notch homolog 3 antibody
      • Notch3 antibody
      see all

    Anti-NOTCH3 antibody images

    • ab92758 at 1/100 dilution staining NOTCH3 in (Bergmann glia-10 micron cryostat sections) rat cerebellum by Immunohistochemistry.

    References for Anti-NOTCH3 antibody (ab92758)

    ab92758 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab92758.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"